Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 19 of the 32 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
Overview
CoChat Summary
TL;DR
This study used post-mortem brain transcriptomics and co-expression network analysis to show that autism spectrum disorder (ASD) cortex has convergent molecular abnormalities, including attenuated frontal-temporal regional expression differences and distinct neuronal and immune-glial co-expression modules. It further links a down-regulated neuronal module to autism genetic association signals and demonstrates A2BP1-dependent differential splicing in ASD brain.
Key findings
- In autism cortex, 444 genes were differentially expressed (DE) versus controls, while only 2 genes were DE in cerebellum; the 209 down-regulated genes were enriched for synaptic function and the 235 up-regulated genes for immune/inflammatory response. In an independent BA44/45 replication cohort, 97 genes were DE and 81 overlapped with the initial cohort (p=1.2E-93), with the same direction of change for all but 2 of the 81.
- Regional cortical patterning was attenuated in ASD: 174 genes were DE between control BA9 and BA41 at FDR<1%, but none were DE in the same regional comparison among ASD cases; relaxing to FDR 5% identified over 500 DE genes in controls and only 8 in ASD brains.
- Weighted gene co-expression network analysis identified an under-expressed neuronal module (M12) enriched for known autism susceptibility genes (p=6.1E-4), including CADPS2, AHI1, CNTNAP2, and SLC25A12, and an up-regulated immune-glial module (M16). M12 showed significant enrichment for autism GWAS association signals (p=5E-4), whereas M16 and the DE gene list did not.
- RNA-Seq on 3 ASD samples with low A2BP1 and 3 controls identified 212 significant alternative splicing events; 36 overlapped with predicted A2BP1/2 targets (p=2.2E-16), and RT-PCR confirmed 85% of tested differential splicing changes involving predicted A2BP1 targets.
Methods
- Post-mortem brain tissue was obtained from the Autism Tissue Project, Harvard Brain Bank, and MRC London Brain Bank. Illumina microarrays profiled superior temporal gyrus (BA41/42), prefrontal cortex (BA9), and cerebellar vermis; after filtering, 58 cortex samples (29 ASD, 29 controls) and 21 cerebellum samples (11 ASD, 10 controls) were analyzed, with an independent BA44/45 replication cohort of 9 ASD cases and 5 controls.
- Analyses included differential expression, supervised hierarchical clustering, weighted gene co-expression network analysis (WGCNA), gene ontology enrichment, and GWAS set enrichment using a published autism GWAS dataset plus negative-control GWAS datasets.
- High-throughput RNA-Seq was performed on 3 ASD samples with significant A2BP1 down-regulation (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels, followed by RT-PCR validation.
Limitations
- The paper does not include a dedicated limitations section.
- The text makes evident that the RNA-Seq comparison used a very small sample (3 ASD, 3 controls) and the replication cohort was also small (9 ASD, 5 controls).
- The study relies on post-mortem brain tissue; potential confounders such as age, sex, RNA integrity number, post-mortem interval, seizure co-morbidity, and medication were assessed, but the authors state that immune changes have no evidence of a common genetic component and are most likely secondary or environmental.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 8 Not checked · 93 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The hubs of M12, i.e. the genes with the highest rank of M12 membership 8 , were A2BP1, APBA2, SCAMP5, CNTNAP1, KLC2, CHRM1 (Supplementary Data).”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation is attached to the definition of module membership used to identify hubs, not to the six-gene list, which the citing sentence attributes to its Supplementary Data. The Results section (“Module membership is highly consistent”; page unavailable) defines module membership, and the Methods section (“Defining a measure of module membership (kME)”; page unavailable) explains how genes are ranked by it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions 8 .”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation supports the sentence’s final clause: the Results sections ‘Conserved modules are enriched for markers of cell classes’ and ‘Relationships between modules are highly preserved’ describe reproducible co-expression modules associated with cell types and biological functions. The similarity of the citing authors’ control network to earlier networks is their own comparison, reported in their Supplementary Table 7, rather than a finding attributed to this source. Page numbers were not available in our copy. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“M12 showed significant overrepresentation of known autism susceptibility genes 2 (Supplementary Table 10; p = 6.1E-4), including CADPS2 , AHI1 , CNTNAP2 , and SLC25A12”
What the sources say
- Partly supportedcites [2] 2. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466:368-372. [PubMed: 20531469] sourceExperimental — accuracy not yet measured
The main text (Figure 2 and the accompanying results; page not provided) discusses a set of ASD-implicated genes, supporting the general description attached to citation 2. Our copy does not identify CADPS2, AHI1, CNTNAP2, or SLC25A12 as members of that set, so it cannot verify the specific examples. The M12 enrichment and p value are presented as the citing paper’s own analysis, not as findings of this source. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The first three of these genes have previously been implicated in autism 14-16”
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Babatz TD, Kumar RA, Sudi J, Dobyns WB, Christian SL. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res. 2009; 2:359-364. [PubMed: 20029827] source
- Supportedcites [15] 15. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010; 19:13681378. [PubMed: 20071347] source
The Abstract identifies SCAMP5 as a candidate gene for autism and reports its disruption in a patient with autism. In the citing sentence’s group of three references, this paper supports the SCAMP5 portion of the claim. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] 16. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B:869-876. [PubMed: 17503474] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“showed significant similarity to two modules identified in previous studies of normal human brain 8 : an astrocyte module and a microglial module.”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The Results section identifies a module of coexpressed genes with characteristics of microglia in human brain. The citation identifies the earlier microglial module; the statement that the citing study’s M16 was significantly similar to it is the citing authors’ comparison, not a finding attributed to Oldham et al. No page number is available in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
95 more claims · 6 with their cited sources checked
Create a free account to see all 117 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although there was no significant DGE in the cerebellum (FDR < 0.05, P distributions in Fig. 1b), similar to observations in a smaller cohort8, there was a replication signal in the cerebellum and overall concordance between ASD-related fold changes in the cortex and cerebellum (Extended Data Fig. 2f–h).”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results are consistent with previous studies in post-mortem brain that identified dysregulation of gene expression in microglia but enriched expression of ASD risk genes only in neuronal cells (Ruzzo et al., 2019; Gandal et al., 2018a, 2018b; Voineagu et al., 2011).”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene expression changes in postmortem brain overlap with developmentally regulated genes involved in cortical patterning as well as in cell cycle, proliferation and neural differentiation6, 7.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis was supported both by the significant overlap between candidate autism-susceptibility genes and Rbfox target genes and by the significant overlap of predicted Rbfox target exons and exons altered in autistic brains with down-regulation of Rbfox1 (Voineagu et al., 2011).”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measured
81 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 5×
“We next applied weighted-gene co-expression network analysis (WGCNA) 8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.”
InfluentialSelf-citationPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“These results indicate that (1) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (2) the upregulation of immune response genes in the autistic brain observed by us and others(25) has no evidence of a common genetic component.”
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Self-citationAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 3×
“%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“In addition, comparison of these DE results with another, smaller study of the STG in ASD 7 , revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).”
Research works printed but not linked: 1
- 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] · DOI · Paper page
Cited by
Items 501–600 of 1,888
Atypical Neurogenesis in Induced Pluripotent Stem Cells From Autistic Individuals
Adhya, D., Swarup, V., Nagy, R., Polit, L. D., Shum, C., Valencia-Alarcón, E. P., Jozwik, K. M., Méndez, M. A., Horder, J., Loth, E., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.014 · Cited by 67
Self-citationEcker, C., Pretzsch, C. M., Bletsch, A., Mann, C., Schäfer, T., Ambrosino, S., Tillmann, J., Yousaf, A., Chiocchetti, A. G., Lombardo, M. V., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.20050630 · Cited by 75
Daimon, C. M., Jasien, J. M., Wood, W. H., Zhang, Y., Becker, K. G., Silverman, J. L., Crawley, J. N., Martin, B., & Maudsley, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00324 · Cited by 66
“Several groups that have already discovered the merit of wide-scale transcriptomic and proteomic studies have produced complex interactomes that offer a more complete disease profile of ASD (Sakai et al., 2011; Voineagu et al., 2011).”
BackgroundGupta, N., Shyamasundar, S., Patnala, R., Karthikeyan, A., Arumugam, T. V., Ling, E.-A., & Dheen, S. T. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1515917 · Cited by 66
Oztan, O., Garner, J. P., Constantino, J. N., & Parker, K. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919050117 · Cited by 65
“It therefore seems more plausible that the AVP signaling pathway may be one of several common biological pathways impacted by the convergence of multiple and diverse ASD susceptibility genes (19).”
BackgroundBinnie, A., Walsh, C. J., Hu, P., Dwivedi, D. J., Fox‐Robichaud, A., Liaw, P. C., Tsang, J. L. Y., Batt, J. A. E., Carrasqueiro, G., Gupta, S., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004097 · Cited by 65
“Correlation of Methylation With Clinical Phenotypes Coexpression network analysis has been used to uncover clinically relevant methylation modules that correlate with phenotype (37, 38).”
MethodMurtaza, N., Cheng, A. A., Brown, C. O., Meka, D. P., Hong, S., Uy, J. A., El-Hajjar, J., Pipko, N., Unda, B. K., Schwanke, B., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111678 · Cited by 65
Zhao, D., Mokhtari, R., Pedrosa, E., Birnbaum, R., Zheng, D., & Lachman, H. M. (2017) · Molecular Autism · doi:10.1186/s13229-017-0134-z · Cited by 69
“Several transcriptome studies show that microglia- and immune/inflammatory-associated genes are among the top DEGs in comparisons made between the ASD and control brains [45, 57, 58].”
BackgroundDillman, A. A., Majounie, E., Ding, J., Gibbs, J. R., Hernandez, D., Arepalli, S., Traynor, B. J., Singleton, A. B., Galter, D., & Cookson, M. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-17322-0 · Cited by 65
Pearl, J. R., Colantuoni, C., Bergey, D. E., Funk, C. C., Shannon, P., Basu, B., Casella, A. M., Oshone, R. T., Hood, L., Price, N. D., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.01.002 · Cited by 64
Damaging de novo mutations diminish motor skills in children on the autism spectrum
Buja, A., Volfovsky, N., Krieger, A. M., Lord, C., Lash, A. E., Wigler, M., & Iossifov, I. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715427115 · Cited by 64
“1E) (2, 26, 27); and chromatin-modulating genes (Fig.”
Griswold, A. J., Dueker, N., Booven, D. V., Rantus, J. A., Jaworski, J. M., Slifer, S. H., Schmidt, M. A., Hulme, W. F., Konidari, I., Whitehead, P. L., et al. (2015) · Molecular Autism · doi:10.1186/s13229-015-0034-z · Cited by 73
“Targets of RBFOX1 splice regulation are enriched for genes involved in neuronal excitation [65] and cytoskeletal reorganization [64].”
BackgroundStambolian, D. E., Wojciechowski, R., Oexle, K., Pirastu, M., Li, X., Raffel, L. J., Cotch, M. F., Chew, E. Y., Klein, B. E. K., Klein, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt116 · Cited by 64
Rare variants in axonogenesis genes connect three families with sound–color synesthesia
Tilot, A. K., Kucera, K. S., Vino, A., Asher, J. E., Baron‐Cohen, S., & Fisher, S. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715492115 · Cited by 67
“A 2011 study of 17 autism cases and 19 controls generated a weighted coexpression network from microarray data from three brain regions (37).”
De novo Mutations (DNMs) in Autism Spectrum Disorder (ASD): Pathway and Network Analysis
Alonso-González, A., Rodriguez‐Fontenla, C., & Carracedo, Á. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00406 · Cited by 87
Bacchelli, E., Cameli, C., Viggiano, M., Igliozzi, R., Mancini, A., Tancredi, R., Battaglia, A., & Maestrini, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-59922-3 · Cited by 72
Satterstrom, F. K., Kosmicki, J. A., Wang, J., Breen, M. S., De Rubeis, S., An, J.-Y., Peng, M., Collins, R., Grove, J., Klei, L., et al. (2018) · doi:10.1101/484113 · Cited by 2,323
“In 6 contrast to post-mortem findings in ASD brains (92, 93), no enrichment was observed in 7 microglia.”
ResultSelf-citationSengar, A. S., Li, H., Zhang, W., Leung, C., Ramani, A. K., Saw, N. M. N., Wang, Y., Tu, Y., Ross, P. J., Scherer, S. W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.087 · Cited by 71
Qin, L., Williams, J. B., Tan, T., Liu, T., Cao, Q., Ma, K., & Yan, Z. (2021) · Nature Communications · doi:10.1038/s41467-021-26972-8 · Cited by 69
Postsynaptic autism spectrum disorder genes and synaptic dysfunction
Bonsi, P., Jaco, A. D., Fasano, L., & Gubellini, P. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105564 · Cited by 72
Network-based approaches for modeling disease regulation and progression
Galindez, G., Sadegh, S., Baumbach, J., Kacprowski, T., & List, M. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.022 · Cited by 79
Schaevitz, L. R., & Berger-Sweeney, J. E. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.322 · Cited by 64
Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders
Jacob, J. (2016) · Epilepsia · doi:10.1111/epi.13272 · Cited by 63
“In silico analyses have attempted to establish the “relatedness” of different gene loci through network modeling approaches using empirical data from high throughput gene coexpression and protein–protein interaction assays.(49,64) These approaches attempt to link genes into functionally related clusters without consid…”
BackgroundMethodRBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior
Fernàndez-Castillo, N., Gan, G., van Donkelaar, M. M. J., Vaht, M., Weber, H., Retz, W., Meyer-Lindenberg, A., Franke, B., Harro, J., Reif, A., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.012 · Cited by 63
Schwede, M., Nagpal, S., Gandal, M. J., Parikshak, N., Mirnics, K., Geschwind, D. H., & Morrow, E. M. (2018) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-018-9237-x · Cited by 83
“dataset samples came from the Autism Tissue Program and the Harvard Brain Bank [17].”
BackgroundMethodInfluentialSelf-citationMaladaptive phenotypic plasticity in cardiac muscle growth is suppressed in high‐altitude deer mice
Velotta, J. P., Ivy, C. M., Wolf, C. J., Scott, G. R., & Cheviron, Z. A. (2018) · Evolution · doi:10.1111/evo.13626 · Cited by 77
“…has been successfully implemented in recent studies that aim to relate gene expression with higher level phenotypic variation (Fuller et al. 2007; Voineagu et al. 2011; Filteau et al. 2013; Plachetzki et al. 2014; Velotta et al. 2016; Campbell-Staton et al. 2017; Campbell-Staton et al. 2018).”
BackgroundSex Differences in Neurodevelopmental Disorders: A Key Role for the Immune System
Breach, M. R., & Lenz, K. M. (2022) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2022_308 · Cited by 62
The phenomenal epigenome in neurodevelopmental disorders
Ciptasari, U., & van Bokhoven, H. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa175 · Cited by 62
Perets, N., Oron, O., Herman, S., Elliott, E., & Offen, D. (2020) · Molecular Autism · doi:10.1186/s13229-020-00366-x · Cited by 64
Pacifico, R., & Davis, R. L. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.94 · Cited by 61
Transcriptomic Insight Into the Polygenic Mechanisms Underlying Psychiatric Disorders
Hernandez, L. M., Kim, M., Hoftman, G. D., Haney, J. R., de la Torre-Ubieta, L., Paşaniuc, B., & Gandal, M. J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.005 · Cited by 70
“Many neuronal processes were dysregulated, particularly in ASD and SCZ, including those related to synaptic signaling and/or regulated by RBFOX1 (40,59,95,97).”
Genes for endosomal NHE6 and NHE9 are misregulated in autism brains
Schwede, M., Garbett, K., Mirnics, K., Geschwind, D. H., & Morrow, E. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.28 · Cited by 61
Self-citationReversal of social deficits by subchronic oxytocin in two autism mouse models
Teng, B. L., Nikolova, V. D., Riddick, N. V., Agster, K. L., Crowley, J. J., Baker, L. K., Koller, B. H., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.025 · Cited by 61
“…function, including GRIN1, which encodes the obligatory NMDAR1 subunit of the N-methyl-D-aspartate (NMDA) receptor (Abrahams and Geschwind 2008; Voineagu et al., 2011; Zeidan-Chulia et al., 2014); however, not all studies have found an positive association between ASD and GRIN1 (e.g. Sanders…”
Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis
Xu, B., Lv, W., Li, X., Zhang, L., & Lin, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28441 · Cited by 69
Jones, H. F., Han, V. X., Patel, S., Gloss, B., Soler, N., Ho, A. C. C., Sharma, S., Kothur, K., Nosadini, M., Wienholt, L. A., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.035 · Cited by 62
“(Lennington et al., 2016; Lisboa et al., 2019; Voineagu et al., 2011) The inflammatory signal reported in brain transcriptomic studies is generally not explained but presumed to be environmental or secondary.”
BackgroundInfluentialSplicing regulation in brain and testis: common themes for highly specialized organs
Naro, C., Cesari, E., & Sette, C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1889187 · Cited by 65
“[91] Voineagu I, Wang X, Johnston P, et al.”
BackgroundGupta, C., Chandrashekar, P. B., Jin, T., He, C., Khullar, S., Chang, Q., & Wang, D. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09438-w · Cited by 76
“The authors demonstrated the alterations in differential splicing associated with A2BP1/FOX1 levels in the ASD brain [157].”
BackgroundMethodBlood-informative transcripts define nine common axes of peripheral blood gene expression
Preininger, M., Arafat, D., Kim, J., Nath, A. P., Idaghdour, Y., Brigham, K. L., & Gibson, G. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003362 · Cited by 59
“These components or modules often seem to correlate with biological features of interest [10,11].”
BackgroundMistry, M., Gillis, J., & Pavlidis, P. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-105 · Cited by 59
“Such coexpression network analyses have recently been applied to a number of postmortem human brain expression profiling datasets for examining general transcriptome patterns of the CNS [6], and to interrogate the molecular basis of neuropsychiatric disease [7-10].”
BackgroundA systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies
Altmann, A., Ryten, M., Nunzio, M. D., Ravizza, T., Tolomeo, D., Reynolds, R. H., Somani, A., Bacigaluppi, M., Iori, V., Micotti, E., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12758 · Cited by 63
Hamada, N., Ito, H., Iwamoto, I., Morishita, R., Tabata, H., & Nagata, K.-I. (2015) · Molecular Autism · doi:10.1186/s13229-015-0049-5 · Cited by 59
“Interestingly, abnormal reduction of RBFOX1 expression in a subset of ASD patient brains was correlated with altered splicing of its predicted targets including two ASD-related genes (GRIN1 and MEF2C), although the pathophysiological relevance of the splicing variation remains to be elucidated [17].”
BackgroundInfluentialTilot, A. K., Bebek, G., Niazi, F., Altemus, J. B., Romigh, T., Frazier, T. W., & Eng, C. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.17 · Cited by 58
Walsh, C. J., Batt, J. A. E., Herridge, M. S., Mathur, S., Bader, G. D., Hu, P., & dos Santos, C. C. (2016) · Scientific Reports · doi:10.1038/srep29334 · Cited by 62
Chen, R., Davis, L. K., Guter, S., Wei, Q., Jacob, S., Potter, M. H., Cox, N. J., Cook, E. H., Sutcliffe, J. S., & Li, B. (2017) · Molecular Autism · doi:10.1186/s13229-017-0130-3 · Cited by 58
“We identified several functional/disease gene sets in ASD for gene set enrichment analysis (GSEA): (1) two lists of RBFOX1 (RNA-binding protein, fox-1 homolog 1)-regulating RNA targets: RBFOX1-1 [44]; RBFOX1-2 [45]; (2) two lists of fragile X mental retardation protein (FMRP) mRNA targets: FMRP-1 [46]; FMRP-2 [47]; (3…”
Barrett, C., Hennessey, T., Gordon, K. M., Ryan, S. J., McNair, M. L., Ressler, K. J., & Rainnie, D. G. (2017) · Molecular Autism · doi:10.1186/s13229-017-0160-x · Cited by 65
“These data are remarkably in line with transcriptomic analysis of the temporal and frontal cortex showing alterations in genes involved in immune function and synaptic plasticity between individuals with and without ASD [85].”
BackgroundResultHoms, A., Codina‐Solà, M., Rodríguez‐Santiago, B., Villanueva, C. M., Monk, D., Cuscó, I., & Pérez‐Jurado, L. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.120 · Cited by 65
Prem, S., Millonig, J. H., & DiCicco-Bloom, E. M. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_5 · Cited by 69
Genetic variation of pre‐mRNA alternative splicing in human populations
Lu, Z., Jiang, P., & Xing, Y. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.120 · Cited by 67
Fenlon, L. R., Liu, S., Gobius, I., Kurniawan, N. D., Murphy, S. J., Moldrich, R. X., & Richards, L. J. (2015) · Neural Development · doi:10.1186/s13064-015-0033-y · Cited by 63
“Recent studies comparing gene expression patterns between ASD patients and controls have shown that the region-specific expression patterns of genes that typically distinguish frontal and temporal cortices, but not the occipital and cerebellar regions, are significantly attenuated in autistic brains [61,62].”
BackgroundEnriched expression of genes associated with autism spectrum disorders in human inhibitory neurons
Wang, P., Zhao, D., Lachman, H. M., & Zheng, D. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0058-6 · Cited by 58
Genetic influence on cognitive development between childhood and adulthood
Mollon, J., Knowles, E. E. M., Mathias, S. R., Gur, R., Peralta, J. M., Weiner, D. J., Robinson, E. B., Gur, R. E., Blangero, J., Almasy, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-018-0277-0 · Cited by 57
Mahfouz, A. E., Ziats, M. N., Rennert, O. M., Lelieveldt, B. P. F., & Reinders, M. J. T. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0641-3 · Cited by 65
“…al. 2012), immune response/apoptosis (Garbett et al. 2008; Voineagu et al. 2011; Chow et al. 2012), neurotransmitter receptors (Purcell et al. 2001), RNA splicing (Voineagu et al. 2011; Ziats and Rennert 2013; Chow et al. 2012), and mitochondrial function (Smith et al. 2012; Anitha et al. 2012b).”
BackgroundInfluentialLoss of MeCP2 function is associated with distinct gene expression changes in the striatum
Zhao, Y.-T., Goffin, D., Johnson, B. S., & Zhou, Z. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.001 · Cited by 57
“This technique has recently been used to identify modules of dysregulated genes in autism patients, providing evidence for convergent molecular pathologies in ASD (Voineagu et al., 2011).”
BackgroundMethodTranscriptome Analysis in Domesticated Species: Challenges and Strategies
Hekman, J. P., Johnson, J. L., & Kukekova, A. V. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s29334 · Cited by 67
Metabolome signature of autism in the human prefrontal cortex
Kurochkin, I., Khrameeva, E., Tkachev, A., Stepanova, V., Vanyushkina, A., Stekolshchikova, E., Li, Q., Zubkov, D., Shichkova, P., Halene, T., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0485-4 · Cited by 57
Frega, M., Selten, M., Mossink, B., Keller, J. M., Linda, K., Moerschen, R., Qu, J., Koerner, P., Jansen, S., Oudakker, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.002 · Cited by 57
“Recent studies have proposed that the genetic heterogeneity among NDDs is buffered at the level of molecular pathways where the effects of many different DNA variants converge (Chen et al., 2014; Gandal et al., 2018; Voineagu et al., 2011).”
BackgroundJafari, M., Wang, Y., Amiryousefi, A., & Tang, J. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01319 · Cited by 62
“The network topology determines the adjacency matrix, which can be utilized for clustering analysis alone or in combination with the similarity matrix derived from the node properties (Von Luxburg, 2006; Fortunato, 2010).”
MethodGating of hippocampal rhythms and memory by synaptic plasticity in inhibitory interneurons
He, X., Li, J., Zhou, G., Yang, J., McKenzie, S., Li, Y., Li, W., Yu, J., Wang, Y., Qu, J., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.014 · Cited by 69
Failed drug discovery in psychiatry: time for human genome-guided solutions
Papassotiropoulos, A., & de Quervain, D. J. ‐. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.02.002 · Cited by 65
Malki, K., Tosto, M. G., Jumabhoy, I., Lourdusamy, A., Sluyter, F., Craig, I., Uher, R., McGuffin, P., & Schalkwyk, L. C. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.154 · Cited by 56
HLA Immune Function Genes in Autism
Torres, A. R., Westover, J. B., & Rosenspire, A. J. (2012) · Autism Research and Treatment · doi:10.1155/2012/959073 · Cited by 56
“A large study that examined SNP data from several genomewide scans on 3,130 subjects with schizophrenia found that the 5 most significant SNP markers are found across the HLA region [31].”
BackgroundSeabury, C. M., Dowd, S. E., Seabury, P. M., Raudsepp, T., Brightsmith, D. J., Liboriussen, P., Halley, Y., Fisher, C. A., Owens, E. K., Viswanathan, G. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062415 · Cited by 59
“Application of the same analysis of divergence to a comparison of the scarlet macaw and zebra finch genomes revealed outlier macaw contigs (Figure 4, Table S14) which were predicted to possess coding and noncoding loci that were also characterized according to known function and/or independent human GWAS results (Tabl…”
ResultMaaswinkel, H., Zhu, L., & Weng, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075955 · Cited by 69
“One of the genes implicated in ASD is GRIN1 which encodes the NMDA-receptor subunit zeta-1 [19].”
BackgroundAutism spectrum disorder: Trends in research exploring etiopathogenesis
Gyawali, S., & Patra, B. N. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12860 · Cited by 77
“Further, transcriptomic analysis can reveal the molecular pathways on which various factors could converge in causation of autism.(24) Transcriptome analyses in ASD have revealed: the loss of cortical patterning gene expression; the disruption of mRNA and long non-coding RNA, whose function still remains unknown; the…”
BackgroundPintacuda, G., Hsu, Y.-H. H., Tsafou, K., Li, K. W., Martín, J. M., Riseman, J., Biagini, J. C., Ching, J. K. T., Mena, D., Gonzalez‐Lozano, M. A., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2022.100250 · Cited by 61
Bonora, E., Graziano, C., Minopoli, F., Bacchelli, E., Magini, P., Diquigiovanni, C., Lomartire, S., Bianco, F., Vargiolu, M., Parchi, P., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303235 · Cited by 58
“CADPS2 maps to the “autism susceptibility locus 1” on chromosome 7q31-q33(Lamb et al , 2005) and is one of the genes that were shown to be downregulated in brains of autistic individuals (Voineagu et al , 2011).”
Autism spectrum disorders: Integration of the genome, transcriptome and the environment
Vijayakumar, N. T., & Judy, M. V. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.026 · Cited by 63
Forés-Martos, J., Catalá-López, F., Sánchez-Valle, J., Ibáñez, K., Tejero, H., Palma‐Gudiel, H., Climent, J., Pancaldi, V., Fañanás, L., Arango, C., et al. (2019) · Molecular Autism · doi:10.1186/s13229-019-0262-8 · Cited by 59
Proteomics Study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children
Shen, L., Feng, C., Zhang, K., Chen, Y., Gao, Y. L., Ke, J., Chen, X., Lin, J., Li, C., Iqbal, J., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00105 · Cited by 60
“The later immuneglial module has less pronounced genetic component and thus is most likely to be either a secondary phenomenon or the result of environmental factors (Voineagu et al., 2011).”
BackgroundWhite matter neuron biology and neuropathology in schizophrenia
Duchatel, R. J., Weickert, C. S., & Tooney, P. A. (2019) · Schizophrenia · doi:10.1038/s41537-019-0078-8 · Cited by 62
Imaging-genetics of sex differences in ASD: distinct effects of OXTR variants on brain connectivity
Hernandez, L. M., Lawrence, K. E., Padgaonkar, N. T., Inada, M., Hoekstra, J. N., Lowe, J. K., Eilbott, J., Jack, A., Aylward, E., Gaab, N., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0750-9 · Cited by 54
Self-citationMuramoto, Y., Shoemaker, J. E., Le, M. Q., Itoh, Y., Tamura, D., Sakai‐Tagawa, Y., Imai, H., Uraki, R., Takano, R., Kawakami, E., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00907-14 · Cited by 57
“We can then use the eigengene of each module (the first principal component of the gene expression matrix), which is a scaled representation of the expression of the genes assigned to each module to explore for potentially strain-dependent responses (55).”
MethodDisruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice
Moy, S. S., Nonneman, R. J., Shafer, G. O., Nikolova, V. D., Riddick, N. V., Agster, K. L., Baker, L. K., & Knapp, D. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.007 · Cited by 55
“…important for synaptic function, including SHANK3, which encodes a member of the post-signaling complex of glutamatergic synapses, and GRIN1, which encodes the obligatory NMDAR1 subunit of the NMDA (N-methyl-D-aspartate) receptor (Abrahams and Geschwind 2008, Geschwind 2011, Voineagu et al. 2011).”
BackgroundGenetics of Complex Traits in Psychiatry
Gelernter, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.005 · Cited by 54
“Gene co-expression network analysis was applied to comparison of brains from subjects with autism and controls(35), first with expression array data and identification of modules of genes that tend to be co-expressed in autism; then combined with autism GWAS data, which associated an expression module (expression [RNA…”
MethodGene regulatory mechanisms underlying sex differences in brain development and psychiatric disease
Manoli, D. S., & Tollkühn, J. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13564 · Cited by 63
Pathways to Drug Development for Autism Spectrum Disorders
Hampson, D. R., Gholizadeh, S., & Pacey, L. K. K. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.245 · Cited by 53
A Magnetization Transfer Imaging Study of Corpus Callosum Myelination in Young Children with Autism
Gozzi, M., Nielson, D. M., Lenroot, R. K., Ostuni, J. L., Luckenbaugh, D. A., Thurm, A. E., Giedd, J. N., & Swedo, S. E. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.026 · Cited by 53
“Another postmortem study (55) analyzed brains from 19 individuals with autism and 17 controls.”
BackgroundA Non-inflammatory Role for Microglia in Autism Spectrum Disorders
Edmonson, C. A., Ziats, M. N., & Rennert, O. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00009 · Cited by 61
Bioinformatics Tools for Genome-Wide Epigenetic Research
Angarica, V. E., & del Sol, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_25 · Cited by 64
Savino, R., Carotenuto, M., Polito, A. N., Noia, S. D., Albenzio, M., Scarinci, A., Ambrosi, A., Sessa, F., Tartaglia, N., & Messina, G. (2020) · Brain Sciences · doi:10.3390/brainsci10090631 · Cited by 63
“Gene networks involved in immune processes seem to be overexpressed in the ASD brain [66,67], linked to atypical expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in a number of cell types in ASD including neurons, astrocytes, and microglia [68,69].”
BackgroundGevezova, M., Sbirkov, Y., Sarafian, V. S., Plaimas, K., Suratanee, A., & Maes, M. H. J. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100646 · Cited by 71
Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses
Maekawa, M., Yamada, K., Toyoshima, M., Ohnishi, T., Iwayama, Y., Shimamoto, C., Toyota, T., Nozaki, Y., Balan, S., Matsuzaki, H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.025 · Cited by 55
Lee, C., Kang, E. Y., Gandal, M. J., Eskin, E., & Geschwind, D. H. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0461-9 · Cited by 51
Self-citationWang, L., Mirabella, V. R., Dai, R., Su, X., Xu, R., Jadali, A., Bernabucci, M., Singh, I., Chen, Y., Tian, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-022-01834-x · Cited by 50
Sarieva, K., Kagermeier, T., Khakipoor, S., Atay, E., Yentür, Z., Becker, K., & Mayer, S. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01997-1 · Cited by 59
“However, SFARI genes of categories 1 – 4 by the old classi fi cation and categories 1-2 by the new classi fi cation were not differentially enriched among DEGs in our single-cell clusters (Supplementary Fig.”
InfluentialHeck, M. V., Azizov, M., Stehning, T., Walter, M. J., Kedersha, N., & Auburger, G. W. J. (2014) · Neurogenetics · doi:10.1007/s10048-014-0397-x · Cited by 58
“In the past, transcriptome profiling has been helpful to document changes in overall transcription and RNA processing, leading to the discovery of altered pathways and signaling networks in human disease [53].”
BackgroundFogel, B. L., Cho, E., Wahnich, A., Gao, F., Bécherel, O. J., Wang, X., Fike, F. M., Chen, L., Criscuolo, C., Michele, G. D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu190 · Cited by 53
“RNA from normal human cerebellar vermis (44) and quantitative real-time PCR (45) were as previously described.”
MethodSelf-citationLi, J., Ma, Z., Shi, M., Malty, R. H., Aoki, H., Minic, Z., Phanse, S., Jin, K., Wall, D. P., Zhang, Z., et al. (2015) · Cell Systems · doi:10.1016/j.cels.2015.11.002 · Cited by 51
“Further examination of its expression in the cerebellar vermis, superior gyrus, and prefrontal cortex(Voineagu et al., 2011) revealed a substantial expression reduction only in the prefrontal cortex among the ASD cases relative to the control subjects (P=0.”
ResultInfluentialDeep brain stimulation for severe autism: from pathophysiology to procedure
Sinha, S. R., McGovern, R. A., & Sheth, S. A. (2015) · Neurosurgical FOCUS · doi:10.3171/2015.3.focus1548 · Cited by 56
Abuhatzira, L., Shamir, A., Schones, D. E., Schäffer, A. A., & Bustin, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300541 · Cited by 58
Role of Microtubule-Associated Protein in Autism Spectrum Disorder
Chang, Q., Yang, H., Wang, M., Wei, H., & Hu, F. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0246-2 · Cited by 53
Ellul, P., Rosenzwajg, M., Peyre, H., Fourcade, G., Mariotti‐Ferrandiz, E., Trebossen, V., Klatzmann, D., & Delorme, R. (2021) · Molecular Autism · doi:10.1186/s13229-021-00472-4 · Cited by 57
Mirza, N., Appleton, R. E., Burn, S. C., Carr, D. F., Crooks, D. A., du Plessis, D., Duncan, R., Farah, J. O., Josan, V., Miyajima, F., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv163 · Cited by 49
Contribution of Long Noncoding RNAs to Autism Spectrum Disorder Risk
Wilkinson, B., & Campbell, D. B. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-418700-9.00002-2 · Cited by 49
RNA-Seq Reveals Novel Transcriptional Reorganization in Human Alcoholic Brain
Farris, S. P., & Dayne Mayfield, R. (2014) · International Review of Neurobiology · doi:10.1016/b978-0-12-801105-8.00011-4 · Cited by 49
Mills, J. D., Kavanagh, T., Kim, W. S., Chen, B. J., Kawahara, Y., Halliday, G. M., & Janitz, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078480 · Cited by 54
“Despite several RNA-Seq-based studies investigating whole transcriptome profiles of cerebral tissue in pathological conditions such as Alzheimer’s disease (AD) [8,9] or autism [10] there has been no systematic attempt to investigate transcriptomic landscape of normal brain tissue with resolution of RNA sequencing.”
BackgroundMeta‐Analysis of Gene Expression in Autism Spectrum Disorder
Ch’ng, C., Kwok, W., Rogić, S., & Pavlidis, P. (2015) · Autism Research · doi:10.1002/aur.1475 · Cited by 56
“To our knowledge, cross-cohort gene expression analyses have only been done in at most two independent ASD cohorts, primarily for cross validation purposes [Kong et al., 2012; Voineagu et al., 2011].”
MethodResultInfluentialFang, G., Passalacqua, K. D., Hocking, J., Llopis, P. D. L. M. M., Gerstein, M., Bergman, N. H., & Jacobs, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-450 · Cited by 54
“We then constructed signed network with β=36 and minimum module size of 5 using the WGCNA default Topological Overlap Matrix ( TOM ) [ 33 ] .”
MethodInfluentialmRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
Barrie, E. S., Smith, R. M., Sanford, J. C., & Sadée, W. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076604 · Cited by 54
“For example, mutations in genes encoding auxiliary splicing factors such as methyl CpG binding protein 2 and RNA binding protein fox-1 homolog (Caenorhabditis elegans) affect multiple downstream targets in autism spectrum disorders and schizophrenia (Smith and Sadee, 2011; Voineagu et al., 2011).”
BackgroundTreatment of autistic spectrum disorder with insulin-like growth factors
Riikonen, R. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.08.005 · Cited by 52
Metadata
- Authors
- Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H.
- Affiliations
- University of California, Los Angeles (US)
- University of Toronto (CA)
- King's College London (GB)
- Corresponding author
- Geschwind, Daniel H.
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7351
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3607626
- OpenAlex
- W1995647101
- Cited by
- 1,874
- References
- 38
- Citations by year
- 2026: 91 · 2025: 93 · 2024: 95 · 2023: 111 · 2022: 112 · 2021: 141 · 2020: 131 · 2019: 142 · 2018: 132 · 2017: 127 · 2016: 143 · 2015: 136 · 2014: 137 · 2013: 124 · 2012: 120
- FWCI
- 67.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Autism Speaks
- Genome Canada
- Ontario Genomics Institute
- National Institutes of Health (5r01mh094714-04)
- Canadian Institutes of Health Research
- Medical Research Council
- National Institute of Mental Health (R01-MH094714, R01MH081754, R37MH060233)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, transcriptome, gene co-expression network, splicing dysregulation, A2BP1, alternative exons, autism susceptibility genes, neuronal dysfunction, genetic heterogeneity
- MeSH terms
- RNA Splicing Factors, Autistic Disorder, Brain, Exons, Frontal Lobe, Gene Expression Regulation, Humans, Temporal Lobe, Transcription, Genetic, Case-Control Studies, RNA-Binding Proteins, Alternative Splicing, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.